Aquestive Therapeutics, Inc.
AQST· Nasdaq
AQSTAquestive Therapeutics, Inc.
Filed Sep 4, 2018 · 10-Q · 66 days after period end · 0001140361-18-037724
| Metric | Q2 2018 | Q2 2017 |
|---|---|---|
| Revenue | $13.93M | $11.14M |
| Net Income | -$36.49M | -$5.90M |
| EPS Diluted | -$1.90 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aquestive Therapeutics, Inc. · CIK 1398733 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Sep 4, 2018 · 66 d after period end
